Continued climb for pharma vaccine revenues

In an industry facing patent expirations and layoffs, vaccine products continue to offer good news, according to health care market research publisher Kalorama Information. The world market for preventative vaccines totaled $25.3 billion in 2010, up from $22.1 billion in 2009, according to its annual report on the industry, Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry. The report notes that the worldwide vaccine market is predicted to increase at a compound annual rate of 9.3% during the next five years, as new product introductions continue and the products are sold to emerging markets. “Vaccines are a priority at the major companies and there has been no let-up in the business in the four years that we have been tracking it annually,” said Bruce Carlson, publisher of Kalorama Information. “We continue to see over nine percent growth in sales, and in some emerging markets the...